Concord Biotech Ltd

NSE: CONCORDBIO · BSE: 543960 · Pharmaceuticals & Biotechnology · 11 announcements

Share price: ₹1,453.60
Market cap: ₹15,207 Cr
Revenue (annual): ₹1,055 Cr
Net profit (annual): ₹260.9 Cr
P/E (TTM): 55.2×Sector 50.4×
Promoter holding: 44.08%+0.00% QoQ
FII holding: 7.53%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 5 Financial Results 2 Bonus Issue 2 Business Update 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

18 Sep 2026 10:22 IST BSE

Business Update

Concord Biotech Business Update

Concord Biotech disclosed a successful USFDA inspection at its Valthera facility with one minor non-GMP observation. No material impact on operations or existing supplies is expected.

Read the filing ↗